Can severe cervical hypertrophy lead to cancer?

Update Date: Source: Network
Cervical Hypertrophy and Cancer Risk

Cervical hypertrophy, particularly severe cases, may pose a risk of cancer development. However, this does not necessarily mean that cervical hypertrophy will inevitably progress to cancer. Professional examinations, such as cervical cancer screening and cervical histopathology, are required to assess the presence of cancerous tendencies. Hypertrophy is often caused by chronic inflammation but may also evolve into pathology, thus cannot be ignored. Common causes of cervical hypertrophy include chronic cervicitis, hormonal imbalance, reproductive system infections, and trauma following childbirth or miscarriage. Untreated chronic cervicitis over a long period may exacerbate the pathological process, leading to cervical hyperplasia and hypertrophy. Further progression of the etiology may be associated with high-risk human papillomavirus (HPV) infection, as HPV is one of the significant causative factors of cervical cancer. External factors such as aging, weakened immunity, and smoking may also adversely affect cervical tissue, increasing the probability of malignant lesions. In the early stages, cervical hypertrophy often presents with mild or no symptoms. Some women may experience increased vaginal discharge, menstrual irregularities, or postcoital bleeding, which require attention.

If cervical hypertrophy is diagnosed, active treatment should be pursued to reduce the risk of cancer. Treatment options include medication, surgery, and daily care. Medications such as cephalosporins and metronidazole can be used to control inflammation. Surgical options like cervical cryotherapy, laser surgery, or LEEP knife treatment can be selected based on medical advice. Daily personal hygiene, regular replacement of sanitary products, and avoidance of frequent unsafe sexual intercourse can reduce the risk of reproductive system infections. Regular cervical cytology (TCT) and HPV screenings can help detect potential lesions early. If symptoms persist or do not improve after treatment, immediate consultation with a gynecologist is recommended to avoid delaying treatment.